3VHD

Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor, CH5164840

3VHD の概要

• エントリーDOI: 10.2210/pdb3vhd/pdb
• 関連するPDBエントリー: 3B24 3B25 3B26 3B27 3B28 3VHA 3VHC
• 分子名称: Heat shock protein HSP 90-alpha, 4-amino-18,20-dimethyl-7-thia-3,5,11,15-tetraazatricyclo[15.3.1.1(2,6)]docosa-1(20),2,4,6(22),17(21),18-hexaene-10,16-dione (3 entities in total)
• 機能のキーワード: chaperone-chaperone inhibitor complex, chaperone/chaperone inhibitor
• 由来する生物種: Homo sapiens (human)
• 細胞内の位置: Cytoplasm: P07900
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 52346.90

構造登録者

Fukami, T.A.,Ono, N. (登録日: 2011-08-24, 公開日: 2012-07-18, 最終更新日: 2024-03-20)

主引用文献

Suda, A.,Koyano, H.,Hayase, T.,Hada, K.,Kawasaki, K.,Komiyama, S.,Hasegawa, K.,Fukami, T.A.,Sato, S.,Miura, T.,Ono, N.,Yamazaki, T.,Saitoh, R.,Shimma, N.,Shiratori, Y.,Tsukuda, T.
Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors
Bioorg.Med.Chem.Lett., 22:1136-1141, 2012

PubMed Abstract: Macrocyclic compounds bearing a 2-amino-6-arylpyrimidine moiety were identified as potent heat shock protein 90 (Hsp90) inhibitors by modification of 2-amino-6-aryltriazine derivative (CH5015765). We employed a macrocyclic structure as a skeleton of new inhibitors to mimic the geldanamycin-Hsp90 interactions. Among the identified inhibitors, CH5164840 showed high binding affinity for N-terminal Hsp90α (K(d)=0.52nM) and strong anti-proliferative activity against human cancer cell lines (HCT116 IC(50)=0.15μM, NCI-N87 IC(50)=0.066μM). CH5164840 displayed high oral bioavailability in mice (F=70.8%) and potent antitumor efficacy in a HCT116 human colorectal cancer xenograft model (tumor growth inhibition=83%).

PubMed: 22192591
DOI: 10.1016/j.bmcl.2011.11.100

実験手法

X-RAY DIFFRACTION (1.52 Å)